Development of an immunoassay for monitoring the levels of ciprofloxacin in patient samples

Journal of Immunoassay

Volumn 19, Issue 4, 1998, Pages 227-238

  Snitkoff, Gail G ^a   Grabe, Darren W ^a   Holt, Richard ^a   Bailie, George R ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Antibiotic; Ciprofloxacin; Immunoassay

Indexed keywords

BOVINE SERUM ALBUMIN; CIPROFLOXACIN; DRUG CARRIER; KEYHOLE LIMPET HEMOCYANIN;

ARTICLE; DRUG DETERMINATION; ENZYME IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; QUANTITATIVE ASSAY;

EID: 0031741033     PISSN: 01971522     EISSN: None     Source Type: Journal    
DOI: 10.1080/01971529808005483     Document Type: Article

References (14)

1. Engvall, E., and Perlmann, P. Enzyme Linked Immunosorbent Assay. Quantitative Assay of Immunoglobulin G. Immunochemistry. 1971; 8: 871-874.
2. Voller, A., Bidwell, D.E., and Bartlett, A. Enzyme immunoassays in diagnostic medicine. Theory and Practice. Bull. World Health Org. 1976; 53: 55-65.
3. Hage, D.S. Immunoassays. Anal. Chem. 1995; 67: 445R-462R
4. Laurie, D., Manson, A.J., Rowell, F.J., et al. A rapid qualitative EIA test for the specific detection of morphine in serum and urine. Clin. Chem. Acta. 1989; 183: 183-196.
5. Raungyuttikarn, W., Law, M., Rollins, D.E., et al. Detection of fentanyl and its analog by enzyme-linked immunosorbent assay. J. Anal. Tox. 1990; 14:160-164
6. Kronkvist, K., Lovgren, U., Edholm, L., et al. Determination of drugs in biosamples at picomolar concentrations using competitive EIA with electrochemical detection: application to steroids. J. Pharm Biomed. Anal. 1993; 11:459-467.
7. Makowski, G.S., Richter, J.J., Moore, RE., et al. An enzyme-linked immunosorbent assay for urinary screening of fentanyl citrate abuse. Ann. Clin. Lab. Sci. 1995; 25: 169-178.
8. Colbert, D.L. Diug abuse screening with immunoassays: unexpected cross-reactivities and other pitfalls. Br. J. Biomed. Sci. 1994; 51: 136-46.
9. Fujiwara, K., Saita, T., Takenawa,N. et al. Enzyme-linked immunosorbent assay for the quantification of actinomycin D using betaD-galactosidase as a label. Cancer Res. 1988; 48: 4843-4847.
10. Poirier, M.C., Reed, E., Shamkhani, H., et al. Platinum drug-DNA interactions in human tissues measured by cisplatin-DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy. Environ. Health Perspect. 1993; 99: 149-154.
11. Blommaert, F.A., van Dijk-Knijnenburg, H.C., Dijt, F.J., et al.Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells. Biochemistry. 1995; 34: 8474-8480.
12. Blecka, L.J., and Jackson, G.J. Immunoassays in therapeutic drug monitoring. Clin. Lab. Med. 1987; 7: 357-370.
13. Vance-Bryan, K., Guay, D.R.P., Rotschafer, J.C. Clinical pharmacokinetics of ciprofloxacin. Clin. Pharmacokinet. 1990; 19 (6): 434-461.
14. Le Bel, M. Ciprofloxacin: Chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy 1988; 8 (1): 3-33.